Camex Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 11, 2025, 11:38 pm

Market Cap	34.9 Cr.
Current Price	34.2
High / Low	78.8/31.5
Stock P/E	10.4
Book Value	42.1
Dividend Yield	0.00 %
ROCE	11.9 %
ROE	8.82 %
Face Value	10.0
PEG Ratio	0.98

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Camex Ltd

Competitors of Camex Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
HP Adhesives Ltd	431 Cr.	47.0	115/42.6	22.3	19.2	0.64 %	17.7 %	12.6 %	2.00
Haryana Leather Chemicals Ltd	38.3 Cr.	78.0	124/56.8	9.30	87.2	1.28 %	8.96 %	7.25 %	10.0
Hardcastle & Waud Mfg Co Ltd	48.3 Cr.	710	1,355/563	27.6	663	0.00 %	7.00 %	5.98 %	10.0
Grauer & Weil (India) Ltd	4,145 Cr.	91.4	120/72.2	25.8	19.2	0.55 %	26.1 %	19.6 %	1.00
DMCC Speciality Chemicals Ltd	765 Cr.	298	453/245	36.7	85.4	0.34 %	7.55 %	2.89 %	10.0
Industry Average	11,704.46 Cr	733.10		47.54	173.82	0.38%	13.99%	10.73%	6.44

All Competitor Stocks of Camex Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	51.33	39.72	30.61	30.58	30.33	40.36	34.13	35.22	34.37	37.59	33.84	34.39	28.21
Expenses	49.48	40.21	29.97	31.03	30.76	39.86	34.42	34.11	33.15	35.49	32.95	33.01	28.58
Operating Profit	1.85	-0.49	0.64	-0.45	-0.43	0.50	-0.29	1.11	1.22	2.10	0.89	1.38	-0.37
OPM %	3.60%	-1.23%	2.09%	-1.47%	-1.42%	1.24%	-0.85%	3.15%	3.55%	5.59%	2.63%	4.01%	-1.31%
Other Income	0.20	3.68	0.39	0.58	0.35	0.62	0.37	0.44	0.52	0.25	0.33	1.15	0.29
Interest	0.24	0.46	0.26	0.18	0.34	0.23	0.25	0.21	0.12	0.18	0.33	0.45	0.31
Depreciation	0.23	0.19	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.07	0.07	0.09
Profit before tax	1.58	2.54	0.69	-0.13	-0.50	0.81	-0.25	1.26	1.54	2.09	0.82	2.01	-0.48
Tax %	17.09%	16.93%	26.09%	-46.15%	-14.00%	23.46%	0.00%	21.43%	24.68%	25.84%	24.39%	27.36%	-35.42%
Net Profit	1.31	2.10	0.51	-0.08	-0.44	0.62	-0.24	0.99	1.16	1.55	0.61	1.46	-0.32
EPS in Rs	1.28	2.06	0.50	-0.08	-0.43	0.61	-0.24	0.97	1.14	1.52	0.60	1.43	-0.31

Last Updated: February 28, 2025, 12:46 pm

Below is a detailed analysis of the quarterly data for Camex Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is ₹28.21 Cr.. The value appears to be declining and may need further review. It has decreased from 34.39 Cr. (Sep 2024) to ₹28.21 Cr., marking a decrease of 6.18 Cr..
For Expenses, as of Dec 2024, the value is ₹28.58 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 33.01 Cr. (Sep 2024) to ₹28.58 Cr., marking a decrease of 4.43 Cr..
For Operating Profit, as of Dec 2024, the value is ₹-0.37 Cr.. The value appears to be declining and may need further review. It has decreased from 1.38 Cr. (Sep 2024) to ₹-0.37 Cr., marking a decrease of 1.75 Cr..
For OPM %, as of Dec 2024, the value is -1.31%. The value appears to be declining and may need further review. It has decreased from 4.01% (Sep 2024) to -1.31%, marking a decrease of 5.32%.
For Other Income, as of Dec 2024, the value is ₹0.29 Cr.. The value appears to be declining and may need further review. It has decreased from 1.15 Cr. (Sep 2024) to ₹0.29 Cr., marking a decrease of 0.86 Cr..
For Interest, as of Dec 2024, the value is ₹0.31 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.45 Cr. (Sep 2024) to ₹0.31 Cr., marking a decrease of 0.14 Cr..
For Depreciation, as of Dec 2024, the value is ₹0.09 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.07 Cr. (Sep 2024) to ₹0.09 Cr., marking an increase of ₹0.02 Cr..
For Profit before tax, as of Dec 2024, the value is ₹-0.48 Cr.. The value appears to be declining and may need further review. It has decreased from 2.01 Cr. (Sep 2024) to ₹-0.48 Cr., marking a decrease of 2.49 Cr..
For Tax %, as of Dec 2024, the value is -35.42%. The value appears to be improving (decreasing) as expected. It has decreased from 27.36% (Sep 2024) to -35.42%, marking a decrease of 62.78%.
For Net Profit, as of Dec 2024, the value is ₹-0.32 Cr.. The value appears to be declining and may need further review. It has decreased from 1.46 Cr. (Sep 2024) to ₹-0.32 Cr., marking a decrease of 1.78 Cr..
For EPS in Rs, as of Dec 2024, the value is -0.31. The value appears to be declining and may need further review. It has decreased from ₹1.43 (Sep 2024) to -0.31, marking a decrease of ₹1.74.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 1:41 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	203	221	147	102	103	121	140	122	143	162	132	142	134
Expenses	197	215	141	98	99	116	134	119	140	159	131	137	130
Operating Profit	6	7	6	4	4	6	7	3	3	2	1	5	4
OPM %	3%	3%	4%	4%	4%	5%	5%	3%	2%	1%	0%	3%	3%
Other Income	0	0	0	0	1	0	0	0	1	5	2	1	2
Interest	3	4	3	2	2	2	2	1	1	1	1	1	1
Depreciation	1	1	1	1	1	1	1	1	1	1	0	0	0
Profit before tax	2	3	2	1	2	3	4	1	2	5	1	5	4
Tax %	31%	33%	33%	33%	34%	34%	23%	29%	18%	17%	29%	25%
Net Profit	2	2	1	1	2	2	3	1	2	4	1	3	3
EPS in Rs	2.19	1.88	1.39	0.90	1.60	2.09	3.08	0.94	1.96	4.13	0.60	3.39	3.24
Dividend Payout %	23%	27%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	0.00%	-50.00%	0.00%	100.00%	0.00%	50.00%	-66.67%	100.00%	100.00%	-75.00%	200.00%
Change in YoY Net Profit Growth (%)	0.00%	-50.00%	50.00%	100.00%	-100.00%	50.00%	-116.67%	166.67%	0.00%	-175.00%	275.00%

Camex Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	-4%
5 Years:	0%
3 Years:	0%
TTM:	-7%

Compounded Profit Growth
10 Years:	6%
5 Years:	2%
3 Years:	21%
TTM:	33%

Stock Price CAGR
10 Years:	2%
5 Years:	26%
3 Years:	4%
1 Year:	-10%

Return on Equity
10 Years:	6%
5 Years:	5%
3 Years:	6%
Last Year:	9%

Last Updated: Unknown

Balance Sheet

Last Updated: February 12, 2025, 2:07 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	7	10	10	10	10	10	10	10	10	10	10	10	10
Reserves	8	10	12	12	14	16	19	20	22	27	27	31	33
Borrowings	40	36	19	14	20	29	14	3	17	9	5	8	10
Other Liabilities	7	10	10	10	11	11	14	17	27	15	16	13	10
Total Liabilities	63	66	51	46	55	66	57	50	77	60	59	61	63
Fixed Assets	4	6	7	7	8	9	9	9	8	3	2	2	6
CWIP	0	0	0	1	0	0	0	0	0	0	0	0	0
Investments	0	0	0	0	0	0	0	0	0	8	0	0	0
Other Assets	59	60	43	38	47	57	48	41	69	50	56	59	57
Total Assets	63	66	51	46	55	66	57	50	77	60	59	61	63

Below is a detailed analysis of the balance sheet data for Camex Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹10.00 Cr..
For Reserves, as of Sep 2024, the value is ₹33.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹31.00 Cr. (Mar 2024) to ₹33.00 Cr., marking an increase of 2.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹10.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹8.00 Cr. (Mar 2024) to ₹10.00 Cr., marking an increase of 2.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹10.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹13.00 Cr. (Mar 2024) to ₹10.00 Cr., marking a decrease of 3.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹63.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹61.00 Cr. (Mar 2024) to ₹63.00 Cr., marking an increase of 2.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹6.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹2.00 Cr. (Mar 2024) to ₹6.00 Cr., marking an increase of 4.00 Cr..
For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹0.00 Cr..
For Investments, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹0.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹57.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹59.00 Cr. (Mar 2024) to ₹57.00 Cr., marking a decrease of 2.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹63.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹61.00 Cr. (Mar 2024) to ₹63.00 Cr., marking an increase of 2.00 Cr..

Notably, the Reserves (₹33.00 Cr.) exceed the Borrowings (10.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	-7	4	24	8	-2	-5	17	12	-15	10	-3	5
Cash from Investing Activity +	-0	-2	-2	-1	-0	-2	-1	-0	1	0	9	1
Cash from Financing Activity +	7	-4	-21	-6	3	7	-17	-12	14	-10	-5	2
Net Cash Flow	-0	-2	0	1	0	-0	-0	0	-0	-0	1	8

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-34.00	-29.00	-13.00	-10.00	-16.00	-23.00	-7.00	0.00	-14.00	-7.00	-4.00	-3.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	80	73	68	87	98	103	82	77	98	70	82	61
Inventory Days	17	18	27	28	44	42	38	31	45	16	31	23
Days Payable	10	13	25	29	28	21	36	47	71	32	45	32
Cash Conversion Cycle	87	78	71	86	115	123	83	61	72	54	67	52
Working Capital Days	88	82	79	98	118	127	86	70	106	76	101	84
ROCE %	11%	11%	10%	8%	9%	11%	12%	6%	7%	7%	5%	12%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	60.05%	59.99%	58.28%	58.28%	58.28%	58.28%	58.28%	48.49%	48.48%	46.96%	44.56%	44.76%
DIIs	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%
Public	39.94%	40.00%	41.71%	41.72%	41.71%	41.72%	41.72%	51.50%	51.51%	53.04%	55.43%	55.23%
No. of Shareholders	3,609	3,638	3,815	3,904	3,821	3,658	3,589	3,607	3,635	4,207	4,113	4,056

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	3.19	1.37	1.21	3.61	2.23
Diluted EPS (Rs.)	3.19	1.37	1.21	3.61	2.23
Cash EPS (Rs.)	3.97	2.27	2.58	4.52	3.02
Book Value[Excl.RevalReserv]/Share (Rs.)	38.95	33.24	31.93	30.55	26.81
Book Value[Incl.RevalReserv]/Share (Rs.)	38.95	33.24	31.93	30.55	26.81
Revenue From Operations / Share (Rs.)	175.58	147.10	129.23	144.20	126.22
PBDIT / Share (Rs.)	2.98	3.36	3.80	7.25	6.17
PBIT / Share (Rs.)	2.12	2.43	2.44	6.34	5.39
PBT / Share (Rs.)	3.99	1.75	1.61	4.54	3.29
Net Profit / Share (Rs.)	3.12	1.33	1.23	3.61	2.23
NP After MI And SOA / Share (Rs.)	3.08	1.33	1.23	3.61	2.23
PBDIT Margin (%)	1.69	2.28	2.93	5.02	4.89
PBIT Margin (%)	1.20	1.65	1.89	4.39	4.26
PBT Margin (%)	2.27	1.19	1.24	3.15	2.60
Net Profit Margin (%)	1.77	0.90	0.95	2.50	1.76
NP After MI And SOA Margin (%)	1.75	0.90	0.95	2.50	1.76
Return on Networth / Equity (%)	8.46	4.00	3.84	11.82	8.32
Return on Capital Employeed (%)	4.46	5.95	7.41	18.00	14.66
Return On Assets (%)	4.83	1.68	2.26	5.96	3.28
Long Term Debt / Equity (X)	0.22	0.20	0.00	0.11	0.32
Total Debt / Equity (X)	0.23	0.51	0.07	0.43	1.09
Asset Turnover Ratio (%)	2.29	2.16	2.19	2.22	1.95
Current Ratio (X)	3.74	1.85	2.10	1.99	1.86
Quick Ratio (X)	2.91	1.45	1.69	1.51	1.48
Inventory Turnover Ratio (X)	3.32	3.77	3.79	2.85	2.69
Interest Coverage Ratio (X)	2.34	4.98	4.56	4.04	2.95
Interest Coverage Ratio (Post Tax) (X)	0.98	2.97	2.48	3.01	2.07
Enterprise Value (Cr.)	35.37	36.38	11.99	44.10	62.50
EV / Net Operating Revenue (X)	0.19	0.24	0.09	0.29	0.48
EV / EBITDA (X)	11.63	10.59	3.09	5.96	9.91
MarketCap / Net Operating Revenue (X)	0.14	0.13	0.07	0.22	0.27
Price / BV (X)	0.71	0.59	0.31	1.04	1.31
Price / Net Operating Revenue (X)	0.14	0.13	0.07	0.22	0.27
EarningsYield	0.11	0.06	0.12	0.11	0.06

After reviewing the key financial ratios for Camex Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 22, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 21) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 22, the value is 3.19. This value is below the healthy minimum of 5. It has increased from 1.37 (Mar 21) to 3.19, marking an increase of 1.82.
For Diluted EPS (Rs.), as of Mar 22, the value is 3.19. This value is below the healthy minimum of 5. It has increased from 1.37 (Mar 21) to 3.19, marking an increase of 1.82.
For Cash EPS (Rs.), as of Mar 22, the value is 3.97. This value is within the healthy range. It has increased from 2.27 (Mar 21) to 3.97, marking an increase of 1.70.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 22, the value is 38.95. It has increased from 33.24 (Mar 21) to 38.95, marking an increase of 5.71.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 22, the value is 38.95. It has increased from 33.24 (Mar 21) to 38.95, marking an increase of 5.71.
For Revenue From Operations / Share (Rs.), as of Mar 22, the value is 175.58. It has increased from 147.10 (Mar 21) to 175.58, marking an increase of 28.48.
For PBDIT / Share (Rs.), as of Mar 22, the value is 2.98. This value is within the healthy range. It has decreased from 3.36 (Mar 21) to 2.98, marking a decrease of 0.38.
For PBIT / Share (Rs.), as of Mar 22, the value is 2.12. This value is within the healthy range. It has decreased from 2.43 (Mar 21) to 2.12, marking a decrease of 0.31.
For PBT / Share (Rs.), as of Mar 22, the value is 3.99. This value is within the healthy range. It has increased from 1.75 (Mar 21) to 3.99, marking an increase of 2.24.
For Net Profit / Share (Rs.), as of Mar 22, the value is 3.12. This value is within the healthy range. It has increased from 1.33 (Mar 21) to 3.12, marking an increase of 1.79.
For NP After MI And SOA / Share (Rs.), as of Mar 22, the value is 3.08. This value is within the healthy range. It has increased from 1.33 (Mar 21) to 3.08, marking an increase of 1.75.
For PBDIT Margin (%), as of Mar 22, the value is 1.69. This value is below the healthy minimum of 10. It has decreased from 2.28 (Mar 21) to 1.69, marking a decrease of 0.59.
For PBIT Margin (%), as of Mar 22, the value is 1.20. This value is below the healthy minimum of 10. It has decreased from 1.65 (Mar 21) to 1.20, marking a decrease of 0.45.
For PBT Margin (%), as of Mar 22, the value is 2.27. This value is below the healthy minimum of 10. It has increased from 1.19 (Mar 21) to 2.27, marking an increase of 1.08.
For Net Profit Margin (%), as of Mar 22, the value is 1.77. This value is below the healthy minimum of 5. It has increased from 0.90 (Mar 21) to 1.77, marking an increase of 0.87.
For NP After MI And SOA Margin (%), as of Mar 22, the value is 1.75. This value is below the healthy minimum of 8. It has increased from 0.90 (Mar 21) to 1.75, marking an increase of 0.85.
For Return on Networth / Equity (%), as of Mar 22, the value is 8.46. This value is below the healthy minimum of 15. It has increased from 4.00 (Mar 21) to 8.46, marking an increase of 4.46.
For Return on Capital Employeed (%), as of Mar 22, the value is 4.46. This value is below the healthy minimum of 10. It has decreased from 5.95 (Mar 21) to 4.46, marking a decrease of 1.49.
For Return On Assets (%), as of Mar 22, the value is 4.83. This value is below the healthy minimum of 5. It has increased from 1.68 (Mar 21) to 4.83, marking an increase of 3.15.
For Long Term Debt / Equity (X), as of Mar 22, the value is 0.22. This value is within the healthy range. It has increased from 0.20 (Mar 21) to 0.22, marking an increase of 0.02.
For Total Debt / Equity (X), as of Mar 22, the value is 0.23. This value is within the healthy range. It has decreased from 0.51 (Mar 21) to 0.23, marking a decrease of 0.28.
For Asset Turnover Ratio (%), as of Mar 22, the value is 2.29. It has increased from 2.16 (Mar 21) to 2.29, marking an increase of 0.13.
For Current Ratio (X), as of Mar 22, the value is 3.74. This value exceeds the healthy maximum of 3. It has increased from 1.85 (Mar 21) to 3.74, marking an increase of 1.89.
For Quick Ratio (X), as of Mar 22, the value is 2.91. This value exceeds the healthy maximum of 2. It has increased from 1.45 (Mar 21) to 2.91, marking an increase of 1.46.
For Inventory Turnover Ratio (X), as of Mar 22, the value is 3.32. This value is below the healthy minimum of 4. It has decreased from 3.77 (Mar 21) to 3.32, marking a decrease of 0.45.
For Interest Coverage Ratio (X), as of Mar 22, the value is 2.34. This value is below the healthy minimum of 3. It has decreased from 4.98 (Mar 21) to 2.34, marking a decrease of 2.64.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 22, the value is 0.98. This value is below the healthy minimum of 3. It has decreased from 2.97 (Mar 21) to 0.98, marking a decrease of 1.99.
For Enterprise Value (Cr.), as of Mar 22, the value is 35.37. It has decreased from 36.38 (Mar 21) to 35.37, marking a decrease of 1.01.
For EV / Net Operating Revenue (X), as of Mar 22, the value is 0.19. This value is below the healthy minimum of 1. It has decreased from 0.24 (Mar 21) to 0.19, marking a decrease of 0.05.
For EV / EBITDA (X), as of Mar 22, the value is 11.63. This value is within the healthy range. It has increased from 10.59 (Mar 21) to 11.63, marking an increase of 1.04.
For MarketCap / Net Operating Revenue (X), as of Mar 22, the value is 0.14. This value is below the healthy minimum of 1. It has increased from 0.13 (Mar 21) to 0.14, marking an increase of 0.01.
For Price / BV (X), as of Mar 22, the value is 0.71. This value is below the healthy minimum of 1. It has increased from 0.59 (Mar 21) to 0.71, marking an increase of 0.12.
For Price / Net Operating Revenue (X), as of Mar 22, the value is 0.14. This value is below the healthy minimum of 1. It has increased from 0.13 (Mar 21) to 0.14, marking an increase of 0.01.
For EarningsYield, as of Mar 22, the value is 0.11. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 21) to 0.11, marking an increase of 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Camex Ltd as of March 12, 2025 is: ₹31.51

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 12, 2025, Camex Ltd is Overvalued by 7.87% compared to the current share price 34.20

Intrinsic Value of Camex Ltd as of March 12, 2025 is: 34.84

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 12, 2025, Camex Ltd is Undervalued by 1.87% compared to the current share price 34.20

Last 5 Year EPS CAGR: 10.58%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has higher reserves (19.31 cr) compared to borrowings (17.23 cr), indicating strong financial stability. The company has shown consistent growth in sales (144.00 cr) and profit (2.69 cr) over the years.	The stock has a low average ROCE of 9.08%, which may not be favorable. The stock has a high average Working Capital Days of 92.92, which may not be favorable. The stock has a high average Cash Conversion Cycle of 79.08, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Camex Ltd:
1. Net Profit Margin: 1.77%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 4.46% (Industry Average ROCE: 13.99%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 8.46% (Industry Average ROE: 10.73%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 0.98
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 2.91
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 10.4 (Industry average Stock P/E: 47.54)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.23
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Camex Ltd. is a Public Limited Listed company incorporated on 22/11/1989 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L17100GJ1989PLC013041 and registration number is 013041. Currently company belongs to the Industry of Chemicals - Speciality. Company's Total Operating Revenue is Rs. 141.81 Cr. and Equity Capital is Rs. 10.21 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Chemicals - Speciality - Others	Camex House, 2nd Floor, Ahmedabad Gujarat 380009	cs@camexltd.com http://www.camexltd.com

Management
Name	Position Held
Mr. Arpit Shah	Independent Director
Mr. Chandraprakash Chopra	Managing Director
Mr. Rajesh Nahata	Executive Director
Mr. Jitendra Chopra	Whole Time Director
Mr. Rahul Chopra	Non Executive Director
Mrs. Tara Jain	Ind. Non-Executive Director
Mr. Uttam Bhandari	Ind. Non-Executive Director
Ms. Indra Singhvi	Independent Director

FAQ

What is the latest intrinsic value of Camex Ltd?

The latest intrinsic value of Camex Ltd as on 11 March 2025 is ₹31.51, which is 7.87% lower than the current market price of 34.20, indicating the stock is overvalued by 7.87%. The intrinsic value of Camex Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹34.9 Cr. and recorded a high/low of ₹78.8/31.5 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹33 Cr and total liabilities of ₹63 Cr.

What is the Market Cap of Camex Ltd?

The Market Cap of Camex Ltd is 34.9 Cr..

What is the current Stock Price of Camex Ltd as on 11 March 2025?

The current stock price of Camex Ltd as on 11 March 2025 is ₹34.2.

What is the High / Low of Camex Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Camex Ltd stocks is ₹78.8/31.5.

What is the Stock P/E of Camex Ltd?

The Stock P/E of Camex Ltd is 10.4.

What is the Book Value of Camex Ltd?

The Book Value of Camex Ltd is 42.1.

What is the Dividend Yield of Camex Ltd?

The Dividend Yield of Camex Ltd is 0.00 %.

What is the ROCE of Camex Ltd?

The ROCE of Camex Ltd is 11.9 %.

What is the ROE of Camex Ltd?

The ROE of Camex Ltd is 8.82 %.

What is the Face Value of Camex Ltd?

The Face Value of Camex Ltd is 10.0.